IP Library Granted Patent US 7,314,630
Granted Patent B2
US 7,314,630 · App. 10/905,527 · Granted Jan 1, 2008

Compounds and methods of early diagnosis of cervical cancer and genital condyloma with HPV, CHSP60 tumor suppressor H-Ras, K-Ras and PTEN derived peptides modified

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,314,630
App. No.
10/905,527
Granted
Jan 1, 2008
Kind
B2
Abstract

An isolated sequence or peptide isolated from an E2, E4, E6, E7 early or late coding region of human papillomavirus (HPV) that is soluble in aqueous medium, and characterized by a linkage to another protein sequence or peptide isolated from the E2, E4, E6, E7 early or late coding region of HPV by a spacer sequence, wherein the isolated protein sequence or peptide consists of more than 50% hydrophilic amino acids, and is recognized by a specific antibody of HPV. Also disclosed are isolated protein sequences or peptides from Harvey Ras (H-Ras), Kirsten Ras (K-Ras), and phosphatase and tensin homologue (PTEN) tumor suppressor proteins and Chlamydia trachomatis heat shock protein 60 (CHSP60 groEL1) and methods for detecting or diagnosing cancer or cellular abnormalities.

Claims (2)

1. An isolated protein sequence or peptide from HPV for detecting or diagnosing cancer or cellular abnormalities, said isolated protein sequence or peptide selected from:

an E6 region of HPV 58 and an E7 region of HPV 16 as set forth in SEQ. ID. No.: 19.

Continuity (1)
Related Publication 20060154238A1 · Jul 13, 2006